The POI Charity Advisory Board (CAB) advises and supports POI in relation to charity partner objectives, outreach initiatives, patient involvement and overall programme strategies. The CAB provides advice on matters relating to raising public awareness, influencing policy, and mobilising resources to fulfil societal missions. The CAB is also responsible for the POI patient engagement and involvement strategy.
Chair, POI Charity Advisory Board
A consultant endocrinologist for over 30 years, Prof Buckley has extensive experience as a principal investigator in clinical trials and has chaired several Independent Data and Safety Monitoring Boards for large cardio-metabolic and rare disease clinical studies. Brendan is Honorary Clinical Professor at UCC and Adjunct Professor at UCD. He was director of UCC’s European Centre for Clinical Trials in Rare Diseases. He has published about 200 papers and chapters including a key book on clinical trials. He was a board member of the Irish Medicines Board (now HPRA) and a member of the European Medical Agency (EMA)’s and Scientific Advisory Group for Diabetes and Endocrinology. He was also a member of the EMA Committee for Orphan Medicinal Products from 2000-2003 and a member of the EMA’s panel of experts. Prof. Buckley previously served as chairman of the Anti-Doping Committee of the Irish Sports Council and is the chairman of the Board of Fighting Blindness. He was Chief Medical Officer of ICON plc 2011-2017. He is co-founder and an executive leader or board director of several companies in the biopharma field.
Chief Executive Officer, Breakthrough Cancer Research
Orla Dolan is a graduate of University College Cork and University of Limerick’s Kemmy Business School. Originally educated as a Microbiologist, she went on to work in Human Resources specifically in Workforce Development and HR systems in the Social and Health Sectors in the United States. While in Delta-T Group, she developed and enforced standards for the front-end processes of the business in all States. She led the transformation of HR practices for over 1500 employees at 22 sites at VisionQuest and was successful in achieving Joint Commission Health Accreditation for the company in multiple States. On returning to Ireland in 2005 she was appointed Director of External Affairs for Cork Cancer Research Centre (CCRC). In 2011 she led the launch of Breakthrough Cancer Research and is now this Irish medical research charity’s Chief Executive. She has been a board member of the National Cancer Registry of Ireland since 2013.
National Breast Cancer Research Institute
Representing the National Breast Cancer Research Institute has given Miriam the opportunity to work with the amazing research team at the Lambe Institute NUI Galway and meet the most incredible fundraisers whose enthusiasm and passion invigorate her daily. The National Breast Cancer Research Institute are honoured to be one of the six Irish cancer charities of Precision Oncology Ireland and Miriam is looking forward to us working together to help achieve a better future for all cancer patients.
Co-Founder and Chief Executive Officer, Breast Cancer Ireland
Aisling is co-founder and CEO of Breast Cancer Ireland. With over 32 years experience in the world of fundraising, Aisling has raised millions of Euro for causes that are close to her, not least those in higher education, health, community, education and NGO arenas.
Chief Executive Officer, National Children's Research Centre
Dr Jacinta Kelly was appointed as Chief Executive of the NCRC in June 2015. Jacinta has a BA (Mod) and a PhD in Immunology from TCD, and an MA in Management. Before joining NCRC in 2009, she gained extensive experience in 3rd level education, and in biomedical research. She is currently a Board Member of the Irish Research Charities Group; a member of the steering group of the Irish Health Research Fourm, and a member of the scientific review committee of St John of God Research Foundation.
Director of Research, Irish Cancer Society
Dr. Robert O’Connor is the Director of Research for the Irish Cancer Society and has >20 years of experience in pharmacology, biosafety, and translational cancer research. Robert graduated from UCD with an honours degree in Pharmacology in 1991 and completed his Ph.D. at the School of Biotechnology in DCU in 1995. Since graduation he has been a Cancer Researcher and Health & Science lecturer in the NICB and School of Nursing & Health Sciences, DCU. He took up the reins to lead the research effort of the Society in 2015.
Robert is passionate about providing the evidence-base to help manage our emerging cancer crisis; focusing on prevention, early detection increased efficacy of diagnostics and therapeutics and supporting Irish cancer survivors to thrive following treatment.
Chief Executive Officer, Oesophageal Cancer Fund
Noelle Ryan is the Chief Executive Officer of the Oesophageal Cancer Fund and lives and breathes the OCF brand values of: Support, Community and Zeal as seen in her hands-on approach across the charity. Her commitment to raise awareness of this difficult cancer in support of a growing, spirited community of patients make her a unique asset, and a fearless leader. She feels fortunate to be surrounded by a terrifically dedicated team, supporting OCF’s ongoing, vital work.